The bone marrow plasma cell labeling index (PCLI) as measured by bromodeoxyuridine uptake is a well-established independent prognostic factor for patients with newly diagnosed multiple myeloma, but the test is not easily done in most laboratories. The purpose of this study was to determine if the pr
Surface light chain phenotype in indolent lymphomas: Lack of prognostic significance
โ Scribed by Louis A. Vandermolen; Patricia L. Duffey; Jeffrey Cossman; Elaine S. Jaffe; Dan L. Longo
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 541 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
โฆ Synopsis
The indolent follicular and diffuse lymphomas are neoplasms of B-cell origin. In several other 6-cell neoplastic disorders, including multiple myeloma, hairy cell leukemia, and chronic lymphocytic leukemia, the light chain isotype of the surface immunoglobulin has been reported to have prognostic significance. Patients with tumors expressing A light chains usually fare more poorly than those with K light chain-bearing tumors. We analyzed the clinical data and immunologic phenotype of 101 patients with indolent lymphoma. Eighty-nine of the 101 patients demonstrated surface immunoglobulin of only one light chain type (K-47, A-42). Patients in both groups were matched for known prognostic factors. There were no significant differences in disease-free survival or overall survival between the two groups or within histologic subtypes. These results indicate that the immunologic light chain phenotype in indolent lymphoma, unlike other B-cell neoplasms, is not a prognostic indicator of survival.
๐ SIMILAR VOLUMES